PDI, Inc. to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call on Tuesday, March 3, 2015

PARSIPPANY, N.J., Feb. 17, 2015 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that it will release its financial and operating results for the fourth quarter and full year ended December 31, 2014 on Tuesday, March 3, 2015 after the market close.  Management will host a conference call beginning at 4:30 pm Eastern time to discuss the results and answer questions.

The dial-in number for the conference call is 877-407-8037 for domestic participants and 201-689-8037 for international participants.  Investors can also access a webcast of the live conference call by linking through the investor relations section of the PDI website, www.pdi-inc.com. 

The teleconference replay will be available two hours after completion through April 3, 2015 at (877) 660-6853 (U.S. and Canada) or (201) 612-7415. The replay passcode is 13601768. The archived web cast will be available for one year on the company's web site, www.pdi-inc.com, under "Investor Relations."

About PDI, Inc.

PDI is a leading healthcare commercialization company providing superior go-to-market strategy and execution to established and emerging healthcare companies through its two core business units. The Company's Commercial Services business unit is a leading provider of outsourced pharmaceutical, medical device and diagnostics sales teams. PDI's Interpace Diagnostics business unit is focused on improving patient care through personalized medicine and molecular diagnostic tests supported by rigorous science. For more information about PDI, Inc. or Interpace Diagnostics, please visit www.pdi-inc.com and www.interpacediagnostics.com.

Forward-Looking Statements

This press release contains forward-looking statements regarding future events and financial performance. These statements are based on current expectations and assumptions involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's, and its subsidiaries', control. These statements also involve known and unknown risks, uncertainties and other factors that may cause PDI's actual results to be materially different from those expressed or implied by any forward-looking statement. For example, with respect to statements regarding the market's acceptance of Interpace Diagnostics products, projections of future revenues, growth and profitability, estimated gross profit and anticipated internal rate of return on investments actual results may differ materially from those set forth in this release based on the loss, early termination or significant reduction of any of our existing service contracts, the failure to meet performance goals in PDI's incentive-based arrangements with customers, the inability to secure additional business or our inability to develop more predictable, higher margin business through in-licensing or other means. Additionally, all forward-looking statements are subject to the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's previously filed Annual Report on Form 10-K for the year ended December 31, 2013 and current reports on Forms 10-Q and Forms 8-K. Because of these and other risks, uncertainties and assumptions, undue reliance should not be placed on these forward-looking statements. In addition, these statements speak only as of the date of this press release and, except as may be required by law, PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Logo - http://photos.prnewswire.com/prnh/20140114/NY45872LOGO 

SOURCE PDI, Inc.

Related Links

http://www.pdi-inc.com